These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 20478050)
1. Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. Biller BM; Colao A; Petersenn S; Bonert VS; Boscaro M BMC Endocr Disord; 2010 May; 10():10. PubMed ID: 20478050 [TBL] [Abstract][Full Text] [Related]
2. The Treatment of Cushing's Disease. Pivonello R; De Leo M; Cozzolino A; Colao A Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718 [TBL] [Abstract][Full Text] [Related]
3. New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy. Fleseriu M; Petersenn S J Neurooncol; 2013 Aug; 114(1):1-11. PubMed ID: 23673515 [TBL] [Abstract][Full Text] [Related]
4. Medical management of functioning pituitary adenoma: an update. Oki Y Neurol Med Chir (Tokyo); 2014; 54(12):958-65. PubMed ID: 25446388 [TBL] [Abstract][Full Text] [Related]
5. Medical treatment of functional pituitary adenomas, trials and tribulations. Capatina C; Hanzu FA; Hinojosa-Amaya JM; Fleseriu M J Neurooncol; 2024 Jun; 168(2):197-213. PubMed ID: 38760632 [TBL] [Abstract][Full Text] [Related]
7. New treatment guidelines on Cushing's disease. Arnaldi G; Boscaro M F1000 Med Rep; 2009 Aug; 1():. PubMed ID: 20948716 [TBL] [Abstract][Full Text] [Related]
8. Medical treatment of Cushing's disease: Overview and recent findings. Praw SS; Heaney AP Int J Gen Med; 2009 Dec; 2():209-17. PubMed ID: 20360906 [TBL] [Abstract][Full Text] [Related]
9. Update on medical treatment for Cushing's disease. Cuevas-Ramos D; Lim DST; Fleseriu M Clin Diabetes Endocrinol; 2016; 2():16. PubMed ID: 28702250 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease. Feelders RA; Fleseriu M; Kadioglu P; Bex M; González-Devia D; Boguszewski CL; Yavuz DG; Patino H; Pedroncelli AM; Maamari R; Chattopadhyay A; Biller BMK; Pivonello R Front Endocrinol (Lausanne); 2023; 14():1165681. PubMed ID: 37876540 [TBL] [Abstract][Full Text] [Related]
11. Impact of medical therapy for hormone-secreting Pituitary tumors on bone. Freda PU Pituitary; 2024 Jul; ():. PubMed ID: 38967763 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis. Broersen LHA; Jha M; Biermasz NR; Pereira AM; Dekkers OM Pituitary; 2018 Dec; 21(6):631-641. PubMed ID: 29855779 [TBL] [Abstract][Full Text] [Related]
13. Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's Disease. Serban AL; Zampetti B; Saladino A; Favero V; Chiodini I; Cozzi R Endocr Metab Immune Disord Drug Targets; 2024; 24(7):845-849. PubMed ID: 37937561 [TBL] [Abstract][Full Text] [Related]
14. Osilodrostat: A Novel Potent Inhibitor of 11-Beta-Hydroxylase for the Treatment of Cushing's Syndrome. Pivonello R; Simeoli C; Paola ND; Larocca A; Crescenzo EM; Colao A touchREV Endocrinol; 2024 Apr; 20(1):43-51. PubMed ID: 38812665 [TBL] [Abstract][Full Text] [Related]
15. Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas. Cheng Y; Wang D; Tang H; Tong D; Zhao W; Lin S; Yao H; Lv W; Zhang X; Xue L; Shang H; Wu ZB Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398117 [TBL] [Abstract][Full Text] [Related]
16. Improving Quality of Life in Patients with Pituitary Tumours. Crespo I; Santos A; Resmini E; Valassi E; Martínez-Momblán MA; Webb SM Eur Endocrinol; 2013 Mar; 9(1):32-36. PubMed ID: 30349608 [TBL] [Abstract][Full Text] [Related]
17. Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Giustina A; Uygur MM; Frara S; Barkan A; Biermasz NR; Chanson P; Freda P; Gadelha M; Haberbosch L; Kaiser UB; Lamberts S; Laws E; Nachtigall LB; Popovic V; Reincke M; van der Lely AJ; Wass JAH; Melmed S; Casanueva FF Pituitary; 2024 Jun; ():. PubMed ID: 38833044 [TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic aspects of the treatment of pituitary gland tumours. Sowiński J; Sawicka N; Piątek K; Zybek A; Ruchała M Contemp Oncol (Pozn); 2013; 17(2):137-43. PubMed ID: 23788980 [TBL] [Abstract][Full Text] [Related]